(January 15, 2013) – Reed Smith LLP today announced the appointment of Yvan-Claude Pierre as Chair of the firm’s U.S. Capital Markets Group. In this newly created role, Pierre is tasked with leading the firm’s U.S. capital markets initiatives and working collaboratively with the firm’s European and Asian capital markets groups to drive the continued expansion of Reed Smith’s global capital markets practice.
“Capital markets in the U.S. has seen a steady uptick in activity, particularly in healthcare and life sciences, and this appointment underscores the firm’s commitment to addressing the constantly evolving needs of our clients,” said Gregory B. Jordan, Global Managing Partner of Reed Smith LLP. “As the new Chair of the firm’s U.S. Capital Markets Group, Yvan-Claude will lead a very talented roster of attorneys and will work in collaboration with the leaders of our other key industry practices, including healthcare, life sciences, financial services and energy to assist the firm in providing high-level client service and continuing our strategic growth.”
Pierre will spearhead Reed Smith’s U.S. capital markets business and lead a team of over 125 attorneys with broad experience across a spectrum of transactions and legal and commercial issues such as: initial public offerings; follow-on public offerings; public unit and debt offerings; tender offers; exchange offers and consent solicitations; private investments in public equities (PIPEs); at-the-market offerings (ATMs); special purpose acquisition company transactions (SPAC); and 144A and Regulation S transactions.
In addition to representing many bulge bracket banks and middle market investment banks, Pierre and his team have built a strong capital markets practice focusing on the healthcare and life sciences sectors. This industry focused capital markets practice bolsters Reed Smith’s leading life sciences healthcare industry group, which represents numerous biotechnology, medical device, pharmaceutical, diagnostics and healthcare services companies, including 11 of the 12 largest global pharmaceutical manufacturers and 50 of the world’s leading medical device manufacturers. Since joining the firm in 2011, the team has closed more than 25 capital markets offerings on behalf of issuers, underwriters and agents within the healthcare and life sciences industries.
“In addition to the 25-plus offerings in the healthcare and life sciences sectors, Pierre’s team closed significant deals in other sectors in 2012 and have succeeded in having the firm recognized as a leader in capital markets work in the U.S.” said Paul J. Jaskot, partner and practice group leader of the firm’s U.S. Corporate and Securities Practice. “The high quality of their work and volume of transactions speaks for itself. We are excited to have him lead the firm’s continued expansion and excellence in the capital markets space.”
Behind Pierre’s leadership, the team has also emerged as one of the leading firms within the investment banking community for the ATM product. With the assistance of partners Daniel I. Goldberg and William Haddad, Reed Smith has closed more ATM offerings in the healthcare, REIT and energy sectors than almost any other law firm in the past 18 months.
Some of the team’s recent transactions include advising:
- Heckmann Corporation in its $80 million follow-on public offering and two high-yield offerings totaling $400 million;
- Nuron Biotech, Inc. in its $80 million debt and equity financing;
- Cantor Fitzgerald, as sales agent, in a $100 million At-the-Market offering of CubeSmart;
- Lazard Capital Markets, as underwriter, in the $50 million SPAC IPO of Aquasition Corp.; and
- Jefferies & Company, Inc., Cantor Fitzgerald & Co., KeyBanc Capital Markets Inc. and RBS Securities Inc, as sales agents, in a $80 million At-the-Market offering of Ramco-Gershenson Properties Trust.
“The recent combination of economic turmoil across the globe, government policy and regulatory uncertainty, and technological advances has changed the capital markets sector. Thus far in 2013, it looks as though capital markets activity is shaping up to be stronger relative to 2012,” said Pierre. “Our capital markets team’s proven experience, combined with the firm’s industry leading healthcare and life sciences, media and technology, financial services and energy industry groups, provides us with the necessary platform to keep up with this increase in activity. I am excited to lead the group as we continue to service clients with sophistication and consistency.”
About Reed Smith
Reed Smith is a global relationship law firm with more than 1,700 lawyers in 23 offices throughout the United States, Europe, Asia and the Middle East. Founded in 1877, the firm represents leading international businesses, from Fortune 100 corporations to mid-market and emerging enterprises. Its lawyers provide transactional, regulatory, tax and litigation advice in multi-jurisdictional and high-stakes matters and executing the full range of strategic domestic and cross-border transactions. Reed Smith is a preeminent advisor to industries including financial services, life sciences, health care, advertising, technology and media, shipping, energy and natural resources, real estate, manufacturing, and education. For more information, visit reedsmith.com.
U.S.: New York, Chicago, Los Angeles, Washington, San Francisco, Philadelphia, Pittsburgh, Princeton, Northern Virginia, Wilmington, Silicon Valley, Century City, Richmond
Europe: London, Paris, Munich, Greece
Middle East: Abu Dhabi, Dubai
Asia: Hong Kong, Beijing, Shanghai, Singapore